Protein Engineering Market - Significant Growth Prospects, Protein Therapy and Top-Selling Biologics Drugs Going Off–Patent in the Near Future

1
MarketsandMarkets Presents
Protein Engineering Market - Significant Growth
Prospects, Protein Therapy and Top-Selling
Biologics Drugs Going OffPatent in the Near
Future
http//www.marketsandmarkets.com/Market-Reports/pr
otein-antibody-engineering-market-898.html
2
The "Protein Engineering Market by Technology
(Rational Protein Design, Irrational Protein
Design), Product (Instrument, Services), Protein
Type (Monoclonal Antibodies, Interferon, Growth
Hormone), End User (Academics Institutes, CROs) -
Global Forecast to 2020", report provides a
detailed overview of the major drivers,
restraints, challenges, opportunities, current
market trends, and strategies impacting the
Protein Engineering market along with the
estimates and forecasts of the revenue and market
share analysis. Browse 100 market data
tables 53 figures 180 pages And in-depth TOC on
Protein Engineering Market Download The PDF
Brochure_at_ http//www.marketsandmarkets.com/pdfdown
load.asp?id898 The global protein engineering
market is poised to reach 1,463.0 million by
2020 from 610.3 million in 2014, at a CAGR of
15.7 from 2015 to 2020.
http//www.marketsandmarkets.com/Market-Reports/pr
otein-antibody-engineering-market-898.html
3
Industry growth is driven increase in adoption of
protein drugs over non-protein drugs, high
prevalence rate of lifestyle diseases, growth in
funding for protein engineering, and reduction in
overall timeline and cost for drug discovery are
the major drivers of the protein engineering
market. However, expensive and high maintenance
tools and instruments used in protein engineering
and dearth of trained personnel are hindering the
market. Request Sample_at_ http//www.marketsandmar
kets.com/requestsample.asp?id898 The protein
engineering market is segmented on the basis of
product, technology, protein type, end user, and
region. By product, the protein engineering
market is categorized into instruments, reagents,
and services and software. The instruments
segment accounted for the largest share 41.4 of
the global protein engineering market in 2014.
http//www.marketsandmarkets.com/Market-Reports/pr
otein-antibody-engineering-market-898.html
4
The protein engineering technology market is
categorized into rational protein design, and
irrational protein design. In this market,
rational protein design is the largest and
fastest growing segment. On the basis of end user
the protein engineering market is classified into
academic research institutes, pharmaceutical and
biotechnology companies, and contract research
organizations. Based on protein type, the market
is categorized into monoclonal antibodies,
insulin, erythropoietin, interferon, colony
stimulating factor, growth hormones, coagulation
factor, vaccines and others (interleukins,
follicle stimulating hormones, enzyme
replacement). Monoclonal antibodies is the
largest as well as fastest growing segment of the
protein engineering protein type market. This
growth is attributed to the increase in adoption
of them for various therapies such as cancer and
autoimmune diseases.
http//www.marketsandmarkets.com/Market-Reports/pr
otein-antibody-engineering-market-898.html
5
Geographically, the protein engineering market is
segmented into North America, Europe, Asia, and
Rest of the World (RoW). North America is further
segmented into U.S. and Canada. Asia is further
segmented into China, Japan, India and Rest of
Asia. In 2014, North America accounted for the
largest share of the protein engineering market,
followed by Europe. Both markets are estimated to
register double-digit growth rates over the next
five years. The major players in protein
engineering market are Agilent Technologies
(U.S.), AB-Sciex (U.S.), Bio-Rad Laboratories,
Inc. (U.S.), Bruker Corp. (U.S.), GE Healthcare
(U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp.
(U.S.), Thermo Fisher Scientific (U.S.), and
Waters Corp. (U.S).
http//www.marketsandmarkets.com/Market-Reports/pr
otein-antibody-engineering-market-898.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/pr
otein-antibody-engineering-market-898.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel [phone] Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets
8
(No Transcript)